Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 969.00 | 782.75 | 1.2379 | 1.3599 | |
| BT-20 | Linsitinib | 1 | uM | 9 | 625.00 | 320.09 | 949.00 | 782.75 | 1.2124 | 1.3220 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 625.00 | 320.09 | 1039.00 | 782.75 | 1.3274 | 1.4910 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 625.00 | 320.09 | 1048.00 | 782.75 | 1.3389 | 1.5077 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 625.00 | 320.09 | 911.00 | 782.75 | 1.1638 | 1.2496 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 943.00 | 782.75 | 1.2047 | 1.3106 | |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 625.00 | 320.09 | 982.00 | 782.75 | 1.2546 | 1.3844 |
| BT-20 | Erlotinib | 10 | uM | 9 | 625.00 | 320.09 | 653.00 | 782.75 | 0.8342 | 0.7379 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 625.00 | 320.09 | 986.00 | 782.75 | 1.2597 | 1.3919 |
| BT-20 | Lapatinib | 10 | uM | 9 | 625.00 | 320.09 | 316.00 | 782.75 | 0.4037 | -0.0099 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 922.00 | 782.75 | 1.1779 | 1.2706 | |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 889.00 | 782.75 | 1.1357 | 1.2074 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 625.00 | 320.09 | 740.00 | 782.75 | 0.9454 | 0.9148 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 529.00 | 782.75 | 0.6758 | 0.4761 | |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 683.00 | 782.75 | 0.8726 | 0.7995 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 625.00 | 320.09 | 796.00 | 782.75 | 1.0169 | 1.0262 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 625.00 | 320.09 | 634.00 | 782.75 | 0.8100 | 0.6986 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 625.00 | 320.09 | 269.00 | 782.75 | 0.3437 | -0.1261 |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 625.00 | 320.09 | 383.00 | 782.75 | 0.4893 | 0.1492 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 625.00 | 320.09 | 811.00 | 782.75 | 1.0361 | 1.0557 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 625.00 | 320.09 | 853.00 | 782.75 | 1.0897 | 1.1378 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 625.00 | 320.09 | 731.00 | 782.75 | 0.9339 | 0.8967 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 625.00 | 320.09 | 304.00 | 782.75 | 0.3884 | -0.0392 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 625.00 | 320.09 | 965.00 | 782.75 | 1.2328 | 1.3523 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 625.00 | 320.09 | 895.00 | 782.75 | 1.1434 | 1.2189 |